{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:02:47Z","timestamp":1774447367334,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/CRTF\/21\/24251"],"award-info":[{"award-number":["FS\/CRTF\/21\/24251"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/21\/10798"],"award-info":[{"award-number":["PG\/21\/10798"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology Plus"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jmccpl.2026.100836","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:18:46Z","timestamp":1770398326000},"page":"100836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective ROCK2 inhibition reduces microvascular obstruction but does not reduce myocardial infarction after ischaemia and reperfusion"],"prefix":"10.1016","volume":"15","author":[{"given":"Lucie","family":"Pearce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean M.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmccpl.2026.100836_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","article-title":"Optimized treatment of ST-elevation myocardial infarction","volume":"125","author":"Niccoli","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0010","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCRESAHA.116.308640","article-title":"The coronary circulation as a target of cardioprotection","author":"Heusch","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0015","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1093\/eurheartj\/ehx288","article-title":"The importance of no-reflow\/microvascular obstruction in the STEMI patient","volume":"38","author":"Kloner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cvr\/cvz301","article-title":"Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction","volume":"116","author":"Konijnenberg","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","article-title":"Ischaemic conditioning and reperfusion injury","volume":"13","author":"Hausenloy","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0030","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI107898","article-title":"The \u201cno-reflow\u201d phenomenon after temporary coronary occlusion in the dog","volume":"54","author":"Kloner","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00395-023-00992-5","article-title":"The RISK pathway leading to mitochondria and cardioprotection: how everything started","volume":"118","author":"Yellon","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00395-017-0657-7","article-title":"The role of PI3Kalpha isoform in cardioprotection","volume":"112","author":"Rossello","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0045","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","article-title":"Critical Issues for the Translation of Cardioprotection","volume":"120","author":"Heusch","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/cvr\/cvz072","article-title":"Shining the spotlight on cardioprotection: beyond the cardiomyocyte","volume":"115","author":"Davidson","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/FJC.0b013e318070d1bd","article-title":"Rho kinase (ROCK) inhibitors","volume":"50","author":"Liao","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","article-title":"RhoA\/Rho-kinase in the cardiovascular system","volume":"118","author":"Shimokawa","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3389\/fphar.2018.01083","article-title":"Fasudil, a rho-kinase inhibitor, exerts cardioprotective function in animal models of myocardial ischemia\/reperfusion injury: a meta-analysis and review of preclinical evidence and possible mechanisms","volume":"9","author":"Huang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0070","doi-asserted-by":"crossref","first-page":"C661","DOI":"10.1152\/ajpcell.00459.2005","article-title":"Physiological role of ROCKs in the cardiovascular system","volume":"290","author":"Noma","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2019.09.057","article-title":"Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia","volume":"297","author":"Kikuchi","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2174\/1570161112666140613115813","article-title":"Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies","volume":"12","author":"Satoh","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0085","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","article-title":"Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina","volume":"105","author":"Masumoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0090","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","article-title":"The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0095","doi-asserted-by":"crossref","first-page":"H550","DOI":"10.1152\/ajpheart.00183.2018","article-title":"No-reflow phenomenon in the heart and brain","volume":"315","author":"Kloner","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","article-title":"Coronary microvascular obstruction: the new frontier in cardioprotection","volume":"114","author":"Heusch","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacc.2021.11.002","article-title":"Intramyocardial hemorrhage: the final frontier for preventing heart failure post-myocardial infarction","volume":"79","author":"Berry","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0110","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.tips.2007.04.006","article-title":"Development of Rho-kinase inhibitors for cardiovascular medicine","volume":"28","author":"Shimokawa","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvy023","article-title":"Vascular smooth muscle contraction in hypertension","volume":"114","author":"Touyz","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","article-title":"Coronary microvascular obstruction in acute myocardial infarction","volume":"37","author":"Niccoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0130","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2019.20","article-title":"Coronary artery spasm: the interplay between endothelial dysfunction and vascular smooth muscle cell hyperreactivity","volume":"15","author":"Hubert","year":"2020","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.108.188524","article-title":"ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells","volume":"104","author":"Wang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0140","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0145","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.bmcl.2016.03.113","article-title":"A review on ROCK-II inhibitors: From molecular modelling to synthesis","volume":"26","author":"Shah","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0155","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12203","article-title":"Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis","volume":"5","author":"K\u00fcmper","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245638","article-title":"Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images","volume":"16","author":"Ram","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acn3.19","article-title":"Selective ROCK2 inhibition in focal cerebral ischemia","volume":"1","author":"Lee","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10557-020-07113-7","article-title":"Effects of OP2113 on myocardial infarct size and no reflow in a rat myocardial ischemia\/reperfusion model","volume":"36","author":"Dai","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0175","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1038\/s41598-022-12749-6","article-title":"Proteomic profiling of concurrently isolated primary microvascular endothelial cells, pericytes, and vascular smooth muscle cells from adult mouse heart","volume":"12","author":"Cao","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2020.04.021","article-title":"Quantitative proteomics characterization of acutely isolated primary adult rat cardiomyocytes and fibroblasts","volume":"143","author":"Poulsen","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004148","article-title":"Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance","volume":"9","author":"Carrick","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00005344-200211000-00013","article-title":"Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study","volume":"40","author":"Shimokawa","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1227\/01.NEU.0000147975.24556.BC","article-title":"Treatment of cerebral vasospasm with intra-arterial fasudil hydrochloride","volume":"56","author":"Tanaka","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1308577","article-title":"Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson\u2019s disease (ROCK-PD)","volume":"16","author":"Wolff","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","article-title":"Rho kinases in cardiovascular physiology and pathophysiology","volume":"98","author":"Loirand","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0210","doi-asserted-by":"crossref","first-page":"H2598","DOI":"10.1152\/ajpheart.01393.2006","article-title":"Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium","volume":"292","author":"Hamid","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0215","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1161\/ATVBAHA.107.152322","article-title":"Involvement of Rho kinase in endothelial barrier maintenance","volume":"27","author":"van Nieuw Amerongen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/j.2040-4603.2017.tb00750.x","article-title":"Regulation of coronary blood flow","volume":"7","author":"Goodwill","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jmccpl.2026.100836_bb0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1165\/rcmb.2019-0435OC","article-title":"KD025 shifts pulmonary endothelial cell bioenergetics and decreases baseline lung permeability","volume":"63","author":"Lee","year":"2020","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Journal of Molecular and Cellular Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976126000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976126000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:20:51Z","timestamp":1774441251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772976126000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S2772976126000036"],"URL":"https:\/\/doi.org\/10.1016\/j.jmccpl.2026.100836","relation":{},"ISSN":["2772-9761"],"issn-type":[{"value":"2772-9761","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective ROCK2 inhibition reduces microvascular obstruction but does not reduce myocardial infarction after ischaemia and reperfusion","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmccpl.2026.100836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100836"}}